ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Role of IV Acetaminophen (APAP) in Reducing Narcotic Use in Live Donor Nephrectomy, The

M. Tan, T. Ommert, R. Cross, M. Mulloy, S. D'Annunzio, M. Johnson, H. Pollinger

Piedmont Hospital, Atlanta

Meeting: 2013 American Transplant Congress

Abstract number: B925

Related Abstracts
  • Benefits of a Robotic Donor Nephrectomy Program: A Series of 100 Consecutive Donors
  • Associations of Pre-Transplant Prescription Narcotic Use With Clinical Complications After Kidney Transplantation

INTRODUCTION: The proliferation of live donor kidney transplant is due in part to the application of minimally invasive surgical techniques. The introduction of robotics to the donor operation, adds another layer of refinement that may improve the donor experience by reducing narcotic use, length of stay, and postoperative pain. The following is our experience using IV APAP administration in the peri-operative period, comparing standard hand assist vs robotic nephrectomy and its impact on post op narcotic use and length of stay.

METHODS: This is a retrospective study of narcotic minimization and a comparison of hand assist vs. robotic assisted live donor nephrectomy at a single center between June and September 2012. In May of 2012, our center approved the use of IV APAP. 22 living kidney donors received intraoperative dosing of IV APAP followed by 3 postop doses q6h in the first 24 hrs. This group was compared to 23 donors in the preceding 6 months who did not received IV APAP. All donors in the study and control groups received ketorolac 30 mg IV q8h in the first 24 hrs post op as part of our standard protocol. Subgroup analysis included a comparison of robotic vs hand-assisted laparoscopic nephrectomy. Primary endpoints were total narcotic usage and length of stay.

RESULTS:

Narcotic Use and LOS with/without APAP
  Control(hand assist+robotic w/o APAP) (n=23) IV APAP(n=22)
Length of stay 2.6 days 2.2 days
PO oxycodone cumulative dose 28 mg 28 mg
IV hydromorphone cumulative dose(p<0.05) 1.5 mg 0.3 mg
Comparison of Laparoscopic vs Robotic Nephrectomies
  Laparoscopic Hand Assist Robotic
  Control(n=17) APAP(n=11) Control(n=6) APAP(n=11)
Overall LOS p=NS 65.1hrs 55.7hrs 53.9hrs 48.8hrs
Mean Oxycodone PO Cumulative Dose 29mg 29mg 24mg 28mg
Mean Hydromorphone IV cumulative dose p<0.05 1.1mg 0.1mg 2.9mg 0.5mg

CONCLUSION:Overall, donors receiving 24 hrs of IV APAP had significantly reduced IV narcotic requirements regardless of hand assist or robotic technique. There is a trend towards decreased length of stay in the robotic group although it is unclear whether this is due to robotic technique, APAP or both. The benefits of reduced narcotic use and the potential for decreased post operative pain associated with IV APAP may potentially decrease donor post operative morbidity and augment overall patient satisfaction. Utilization of robotic techniques may also help decrease LOS although it did not achieve significance in this study and warrants further investigation.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tan M, Ommert T, Cross R, Mulloy M, D'Annunzio S, Johnson M, Pollinger H. Role of IV Acetaminophen (APAP) in Reducing Narcotic Use in Live Donor Nephrectomy, The [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/role-of-iv-acetaminophen-apap-in-reducing-narcotic-use-in-live-donor-nephrectomy-the/. Accessed April 22, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.